Provided by Tiger Fintech (Singapore) Pte. Ltd.

Repligen

141.51
+4.313.14%
Post-market: 141.510.00000.00%16:32 EDT
Volume:581.93K
Turnover:82.02M
Market Cap:7.95B
PE:-337.81
High:142.66
Open:140.36
Low:138.32
Close:137.20
Loading ...

QGEN or RGEN: Which Is the Better Value Stock Right Now?

Zacks
·
Yesterday

Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare

Insider Monkey
·
Yesterday

Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): ‘Arguably The Most Innovative Biopharma Company I’ve Seen In The Last Two Decades’

Insider Monkey
·
Yesterday

Jim Cramer on Repligen Corporation (RGEN): ‘I’m Not Quite Ready to Stick My Neck Out on This One’

Insider Monkey
·
Yesterday

Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y

Zacks
·
30 Apr

RBC Lowers Price Target on Repligen to $189 From $202, Keeps Outperform Rating

MT Newswires Live
·
30 Apr

Repligen Corp : Leerink Partners Raises Target Price to $200 From $180

THOMSON REUTERS
·
30 Apr

Repligen Corp (RGEN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com
·
30 Apr

Q1 2025 Repligen Corp Earnings Call

Thomson Reuters StreetEvents
·
30 Apr

Repligen’s Earnings Call Highlights Robust Growth and Strategic Moves

TIPRANKS
·
30 Apr

Repligen Is Maintained at Overweight by JP Morgan

Dow Jones
·
30 Apr

Wolfe Research Upgrades Repligen to Outperform From Peerperform

MT Newswires Live
·
30 Apr

Repligen Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
29 Apr

Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH), Repligen (RGEN) and CareDx (CDNA)

TIPRANKS
·
29 Apr

Repligen (RGEN) Tops Q1 Earnings and Revenue Estimates

Zacks
·
29 Apr

Repligen Q1 Adj. EPS $0.39 Beats $0.35 Estimate, Sales $169.17M Beat $163.83M Estimate

Benzinga
·
29 Apr

BRIEF-Repligen Q1 Adjusted EPS USD 0.39 Vs. IBES Estimate USD 0.35

Reuters
·
29 Apr

Repligen Outlook FY Adjusted EPS USD 1.63-1.72

THOMSON REUTERS
·
29 Apr

Repligen Corp: Reiterates 2025 Full Year Organic Revenue Guidance of 9.5% - 13.5%

THOMSON REUTERS
·
29 Apr

Repligen Q1 Adjusted Net Income USD 22 Million VS. Ibes Estimate USD 19.6 Million

THOMSON REUTERS
·
29 Apr